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Abstract   
Introduction: Helicobacter pylori (H. pylori) infection has remained as a global health 
problem. Animal studies demonstrated the role of H. pylori oipA gene in the development of 
gastric cancer. The aim of this study was the cloning and expression of Helicobacter pylori 
oipA gene in a bicistronic vector harboring mice IL-18 gene. 
Materials and methods: The target gene encoding oipA was amplified from a codon-
optimized clone by PCR, and then double-digested by restriction enzymes. The pIRES-
Igk/mIL18/Fc plasmid was simultaneously digested by BstXI/NotI enzymes to elicit the 
eGFP segment. PCR product of oipA was inserted into pIRES-Igk/mIL18/Fc plasmid using 
T4 ligase. Transformation into DH5α strain was done. Cloning was confirmed by PCR, 
enzymatic digestion and sequencing. Expression of the oipA and IL-18 mRNA was assessed 
by means of TaqMan Real-time PCR. 
Results: Electrophoresis of PCR product, enzymatic digestion and sequencing showed that 
the H. pylori oipA gene was successfully cloned into pIRES-Igk/mIL18/Fc to generate mIL-
18-pIRES2-oipA plasmid. The results of Real-time PCR confirmed the successful expression 
of both oipA and IL-18 in mouse macrophage cell line. 
Conclusion: Considering the role of oipA in pathogenesis of H. pylori and potent activity of 
IL-18 as a molecular adjuvant, the results of the present study showed that the expression of 
codon-optimized oipA gene in bicistronic vector including mouse IL-18 is successful. So, it 
could be considered as an appropriate genetic vaccine candidate for H. pylori in future 
investigations. 
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Introduction  
Helicobacter pylori is a Gram negative, 
motile, spiral-shaped, and microaerophilic 
microorganism. This bacterium is one of 
the most important human pathogens that 
infect more than half of the population 
worldwide (1). H. pylori is a most 
important causative agent in some gastro-
duodenal diseases including duodenal 
ulcer, peptic ulcer, chronic active gastritis, 
*Corresponding author:Tel: +98 1333690921-229  Fax: +98 1333690036   
Address: Department of Microbiology, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, 
Iran 
E-mail:  shenagari@gmail.com 



































Original article                                                                   J Bas Res Med Sci 2017; 4(3):1-7.  
2 
 
gastric adenocarcinoma, and MALT 
lymphoma (2). 
To date, a number of virulence factors 
including cagA and vacA genes concerned 
to severe stomach illnesses such as gastric 
ulcers and gastric cancer have been 
identified (3). Almost 4% of the H. pylori 
genome encodes outer membrane proteins 
(OMPs), some of which act as adhesin (4). 
OipA (Outer inflammatory protein A) is 
one of the outer membrane proteins which 
involve in bacterial adhesion. Several 
studies showed that the oipA gene is 
another important virulence factor 
associated with gastric ulcers and cancer 
(5). Interleukin 18 (IL-18) is considered as 
a pro-inflammatory cytokine and inducer 
factor of interferon γ (IFN-γ) production 
by NK cells and CTL (6). Moreover it also 
increases Fas dependent cell death (Fas-
Dependent Cytotoxicity) and Perforin in 
these cells. On the other hand, this 
cytokine plays an essential role in T helper 
Lymphocyte activities (T helper 1) (7, 8). 
Structurally, IL-18 belongs to the super 
family of IL-1 and is synthesized in 
inactive and non- secretory precursor form 
as same as IL-1β (9). The main 
characteristic of this cytokine in 
stimulation of CTL and NK cells and 
following increased cell killing activity has 
led to be used in the vaccine research and 
tumor immunotherapy (10). Therefore, this 
cytokine can be used as adjuvant to 
increase vaccine efficiency especially in 
DNA vaccine protocols (11-13). The 
importance of OipA in pathogenesis of H. 
pylori from one side and the adjuvant 
activity of IL-18 ,especially in TH1 
shifting, from other side, persuaded us to 
design a study to construct a genetic 
material containing H. pylori oipA and 
mouse IL-18 genes to assess its 
immunogenicity in the future 
investigations. 
Material and methods 
In order to clone the target genes, H. pylori 
oipA and murine IL-18, the pIRES2-eGFP 
vector (Clontech, Takara Bio Company, 
Shiga, Japan) was applied as expression 
vector. This bicistronic vector allows the 
expression of two separate protein from 
the same mRNA by employing IRES 
(Internal Ribosome Entry Site) element. 
As described in previous study, the 
plasmid containing mouse IL-18 gene 
fused to murine IgG1 Fc (Fcy2a) and 
signal sequence of immunoglobulin kappa 
(IgK) (pIRES-Igk/mIL-18/Fc) was 
constructed after implementing several 
cloning and sub-cloning process. As a 
summary, total RNA of stimulated 
spleenocytes was extracted and reverse 
transcribed to produce cDNA of murine 
IL-18 and Fcy2a. mIL-18/Fc mixed 
segment was constructed by insertion of 
Fc fragment and mIL-18 into pSL1180 
plasmid. In the following, addition of 
kappa sign was accomplished by sub-
cloning of mIL-18/Fc into pSectag2a 
plasmid. Finally, Igk/mIL-18/Fc was 
cloned into pIRES2-eGFP vector using 
NheI/XmaI enzymes to construct pIRES-
Igk/mIL-18/Fc plasmid. Identification and 
confirmation of cloned mIL-18 was 
assessed by enzymatic digestion, 
sequencing and ELISA (14). 
Codon-optimization of oipA gene: The 
objective of the present study was cloning 
of H. pylori oipA gene into previously 
constructed pIRES-Igk/mIL-18/Fc 
plasmid. For this purpose, the eGFP 
coding sequence must be replaced by the 
desired sequence just after IRES element, 
using BstXI and NotI restriction enzymes. 
Regarding to the existence of BstXI 
restriction site within H. pylori oipA gene, 
codon optimization strategies was used to 
eliminate it and improvement of 
translational efficiency based on Mus-
musculus codon usage. Modified sequence 
accuracy was analyzed by NEBcutter V2.0 
(New England Biolabs, U.S.A.), SnapGene 
(GSL Biotech LLC.), BlastX, and Mega 
6.0 softwares. The codon-optimized oipA 
sequence was constructed in BioNeer Co. 
(Daejeon, Korea). 
oipA PCR: The plasmid harboring 
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for amplification and cloning of this gene 
into previously constructed pIRES-
Igk/mIL-18/Fc plasmid. The primers 
containing restriction sites for BstXI and 
NotI enzymes were designed using 
AlleleID v6.0 (PREMIER Biosoft 
International, USA) and OLIGO 7 
(Molecular Biology Insights, Inc., CO, 
USA) and constructed in BioNeer Co. 
(Daejeon, Korea) (Table 1). The oipA 
gene was amplified using Pfu DNA 
polymerase by PCR with initial 
denaturation at 94 ˚C for 4 min, followed 
by 25 cycles of denaturation at 94 ˚C for 
20s, annealing at 60 ˚C for 20s, elongation 
at 72 ˚C for 2 min and final extension at 72 
˚C for 10 min. The final concentrations of 
reagents in 50 µl PCR reaction were as 
follows: 1X PCR buffer, 2.5mM MgCl2, 
1mM dNTP, 50 pmol primers and 15 ng 
plasmid DNA as template. PCR product 
was electrophoresed on a 0.8% low 
melting agarose gel at 70V for 2 h. and 
purified using QIAquick gel extraction kit 
(Qiagen, Valencia, CA) according to 
manufacturer’s protocol . 
Cloning of oipA gene: Amplified oipA 
gene and pIRES-Igk/mIL-18/Fc plasmid 
were double-digested by FastDigest BstXI 
and fastDigest NotI (Thermo Fisher 
Scientific, U.S.A). Digested PCR product 
and plasmid were purified by QIAquick 
gel extraction kit. Ligation reaction was 
performed using DNA Ligation kit (Takara 
Bio Company, Shiga, Japan). The 
considered molar ratio of vector to insert 
was 1:3. The recombinant plasmid was 
transformed into E. coli DH5α by heat-
shock protocol and calcium chloride 
treatment. Finally transformants were 
selected on LB agar containing 50 μg/ml 
kanamycin (Sigma-Aldrich, USA) . 
Confirmation of Cloned DNA: Colony 
PCR was conducted using specific primers 
to evaluate the existence of insert in 
bacterial colonies. Positive colonies 
according to PCR results were selected 
and inoculated into LB broth medium 
containing 50 μg/ml kanamycin. QIAprep 
Spin Miniprep kit (Qiagen, Valencia, CA) 
was utilized for extraction of plasmids. 
The accuracy of the cloned oipA gene was 
verified by enzymatic digestion and 
bidirectional sequencing (BioNeer 
Company, Korea). The sequence of used 
primers in colony PCR and bidirectional 
sequencing were shown in table 1. 
 
Table 1. List of primer sequences used for cloning of oipA gene in this study. 
The oipA cloning PCR primers sequences (Amplicon: 954 bp) 
oipA F (BstXI) 5' CTAACCACAACCCGTGGATGAAGAAGGCCCTGTTG 3' 
oipA R (NotI) 5' CGGCGCGGCCGCTAATGTTTGTTTTTAAAG 3' 
The sequences of oipA colony PCR primers (Amplicon: 459 bp) 
oipA-con F 5’  CAACCGTGGATGAAGAAG 3’ 
oipA-con R 5’  GGTATTGAAGCCGTATGG 3’ 
The sequences of oipA bidirectional sequencing primers 
oipA-seq F 5’ GCTTTACATGTGTTTAGTCGAGGTT 3’ 
oipA-seq R 5’ CCTCTACAAATGTGGTATGGCTGATT 3’ 
PCR, polymerase chain reaction. F, forward. R, reverse.  
 
Transfection of mIL-18-pIRES2-oipA 
plasmid: The expression of cloned genes 
were assessed in eukaryotic cell lines by 
transfection of constructed mIL-18-
pIRES2-oipA plasmid into murine 
macrophage-lineage, RAW 264.7 cell 
lines. The cells were transfected at 70-90% 
confluence using Lipofectamine 2000 
(Invitrogen, U.S.A.) with 100 ng of three 
different plasmids including mIL-18-
pIRES2-oipA, pIRES-Igk/mIL-18/Fc (As 
negative control for oipA gene) and 
pIRES2-eGFP (As positive control of 
transfection) according to manufacturer’s 
protocol.  The efficiency of transfection 
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Assessment of mIL-18 expression and 
bioactivity: As previously described by 
Pouriayevali et al,(14) the expression and 
bioactivity of cloned mIL-18 from 
constructed plasmid were evaluated by 
mouse IL-18 ELISA kit (Bender 
MedSystems, Austria) and Mouse IFN-γ 
ELISA (U-cytech bioscience, Netherlands) 
after harvesting the supernatants of 
transfected RAW 264.7 cell line  
according to recommendation of 
manufacturers. 
Assessment of oipA expression: To 
evaluate the expression of cloned oipA 
gene in transfected cells, TaqMan Real-
time PCR technique was used. Total RNA 
was extracted from transfected RAW 
264.7 cells using the RNeasy Mini Kit 
(Qiagen) and  reverse transcription of 
RNA into cDNA was carried out by High-
Capacity cDNA Reverse Transcription Kit 
(Applied Biosystem, U.S.A.). TaqMan 
Real-time PCR assay for evaluation of 
codon-optimized oipA and mIL-18 genes 
expression was accomplished by designing 
specific primer and probe using AlleleID 
software (Table 2). TaqMan Universal 
PCR Master Mix (Applied Biosystem, 
U.S.A.) and StepOnePlus Real-time PCR 
system (Applied Biosystem, U.S.A.) were 
utilized for running the reaction. The 
selected method was End-point detection 
Real-time PCR. The housekeeping 
mGAPDH (murine glyceraldehyde-3-
phosphate dehydrogenase) reference gene 
was considered as Internal Positive 
Control (IPC). The Real-time PCR 
reactions were carried out in total volume 
of 20 µl using 10 pmol of specific primer 
and probes for oipA and mIL-18 
separately under the following conditions: 
60°C for 30s (Pre-PCR plate read), 50°C 
for 2 min and 95°C for 10 min (Holding 
Stage), followed by 45 cycles of 95°C for 
15s, 60°C for 1 min (Cycling stage) and 
60°C for 30s (Post-PCR plate read). mIL-
18-pIRES2-eGFP and pIRES2-eGFP were 
used as positive and negative control 
respectively.
 
Table 2. The designed primers and probes sequences for Real-time PCR reaction 
5' AAATGCCCAGCACCTAACCTC 3' mIL-18 -F 
5' GGTCATCCTCGCTCACATCC 3' mIL-18-R 
5' FAM/ACCATCCGTCTTCAT/NFQ-MGB 3' mIL-18-TaqMan 
5' ATGTTCCAGTATGACTCCACTCAC 3' mGAPDH-F 
5' GCTCCTGGAAGATGGTGATGG 3' mGAPDH-R 
  5' VIC/ATTCAACGGCACAGTC/NFQ-MGB 3' mGAPDH-TaqMan 
5' GAAGGCTTCTGCACAGAATGC 3' Mod-oipA-F 
5' CGGTTAGCGATTTTGTTTGAATCC 3' Mod-oipA-R 
5' FAM/CCAAGCCATCAACAA/NFQ-MGB 3’ Mod-oipA-TaqMan 
PCR, polymerase chain reaction. F, forward. R, reverse.  
Results 
Codon-optimization of oipA: The 
sequencing analysis of ordered plasmid 
containing modified oipA gene 
demonstrated the deletion of BstXI 
restriction site in codon-optimized oipA 
sequence. Nonetheless, BlastX results 
confirmed complete homology of codon-
optimized and native oipA in coding 
protein level.  
oipA PCR: The electrophoresis of oipA 
PCR product confirmed the presence of 
desired 954 bp fragment concerned to this 
gene (Figure 1). 
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Confirmation of cloned DNA: The 
authenticity of cloned DNA was verified 
by enzymatic digestion, PCR and 
sequencing. As shown in Figure 2 the 
inserted 954 bp fragment was brought out 
after double digestion with BastXI and 
NotI. Also 459 bp amplicon was produced 
by plasmid while added as a template in 
PCR reaction. Analysis of bidirectional 
sequencing proved complete accuracy of 
cloned gene.  
 
   
Figure 2. Electrophoresis of confirmatory double 
digestion.  
 
Recombinant mIL-18 expression and 
bioactivity: Assessment of murine IL-18-
Fcy2a fusion protein expression and 
biological activity in supernatant of RAW 
264.7 cells showed the production of mIL-
18 near 250 pg/ml and IFN-γ (as a 
bioactivity indicator) almost 20 pg/ml.   
Codon-optimized oipA expression: 
Endpoint TaqMan Real-time PCR assay 
results showed the successful expression 
of oipA and mIL-18 genes from mIL-18-
pIRES2-oipA plasmid in transfected RAW 
264.7 cells in comparison to pIRES2-
eGFP (as negative control). 
Discussion 
Despite great progress in H. pylori vaccine 
design, the mechanisms of mucosal 
immunity against this bacterium is unclear 
up to now. In fact, it is surprising that 
proteins such as urease and heat shock 
protein homologues which are present in 
the cytoplasm of other intestinal pathogens 
may be serves as vaccines against H. 
pylori. Successful H. pylori vaccination 
strategies were evaluated in different 
animal models by oral administration of H. 
pylori antigens in combination with 
mucosal adjuvants such as cholera toxin 
and E. coli LT enterotoxin. Various 
antigens have been used as prophylactic or 
therapeutic H. pylori vaccines in animal 
models. Chen et al in 2012 reported that 
injection of the recombinant OipA protein 
in combination with IL-2 molecular 
adjuvant and pLTB genes could be 
effective against H. pylori by reducing the 
bacterial load in immunized mice (16). In 
another study, Chen and colleagues 
showed that injection of genetic vaccine 
expressing oipA loaded on attenuated 
Salmonella typhimurium strain in C57 
mice can effectively stimulate cellular and 
humoral immunity (18). Falivene et al in 
2012 showed the importance of IL-18 
cytokine in effective immunization 
strategies against antigens carried by MVA 
vector (Modified Vaccinia Ankara) by 
deleting IL-18 binding protein gene in this 
vector (17). Due to the ability of IL-18 in 
stimulation of innate and adaptive immune 
responses and Th1 shifting, DNA vaccine 
containing IL-18 molecular adjuvant 
sounds appealing strategies in preventing 
of classic and re-emerging diseases (19). 
Several advantages have been cited for 
fusion of murine Fcy2a to cytokines 
including increased avidity, prolonged 
circulating half-life due to molecular size 
increase and reduced renal clearance. 
Furthermore, fusion with Fc results in 
alteration of complement-mediated and 
antibody dependent cell-mediated 
cytotoxicity, enhancing the effects of IL-
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Considering OipA virulence and 
carcinogenesis, the aim of present study 
was to build a bicistronic plasmid 
containing codon-optimized H. pylori 
oipA and murine IL-18 genes to assess 
immunogenicity of this plasmid in animal 
models in future studies. Selection of a 
bicistronic vector enabled us to express 
both oipA and IL-18 genes from the same 
construct. Applying two plasmids in DNA 
vaccine projects can hamper the 
reproducibility of experiments, so 
bicistronic vector was used to ensure equal 
molar ratio of genes (Equimolar) in DNA 
vaccine formulation in ongoing study. The 
results of sequencing, transfection and RT-
PCR showed that H. pylori optimized oipA 
gene as well as murine IL-18 were 
expressed successfully from constructed 
mIL-18-pIRES2-oipA plasmid in 
monocytes / macrophages cell line. 
Moreover, the application of this construct 
is possible as a promising H. pylori DNA 
vaccine candidate.  
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